Max Bayer

Max Bayer, with the LinkedIn username max-bayer-20435179, is a journalist specializing in the pharmaceutical industry. Here are some key points about his career and experience:

Current Role

• He is currently a Pharma Reporter at Endpoints News, a position he started in May 2024.13

Previous Roles

• Before joining Endpoints News, he worked as a Senior Writer and Staff Writer at FierceMarkets from February 2022 to May 2024, covering drug development and the investors financing new research for Fierce Biotech.1
• He was a Reporter and Researcher, and later an Associate Producer, at CBS News from May 2019 to December 2021. During his time at CBS News, he covered COVID-19 infection trends, vaccine developments, and the CDC. He also wrote breaking news and enterprise stories, collected and analyzed data, and fact-checked copy for the CBS Evening News.1

Early Career

• Max Bayer has a diverse background in journalism, having worked as a News Associate at CBS News, a Statehouse Intern at the Milwaukee Journal Sentinel, and in various roles at The Daily Cardinal, including City News Editor and News Reporter. He also interned at WisPolitics.com and RotoWire, and was a Collegiate Correspondent for USA TODAY.1

Education and Other Experience

• Although the specific educational background of this Max Bayer is not detailed in the provided sources, his extensive experience in journalism and reporting is well-documented.

Max Bayer is actively engaged in covering the pharmaceutical industry and has recently expressed his excitement about joining the Endpoints News team.23